seekingalpha.com · 4 jul

McKesson: The Healthcare Supplier On My Buy List This Summer, As Growth Accelerates

McKesson (MCK) is rated a buy, offering capital growth and dividend potential, underpinned by robust top-line and EPS growth. MCK's diversified portfolio, role in oncology and collaboration with big pharma names like AbbVie, and investment-grade Fitch rating support its investment case despite negative equity. Valuation appears compelling, with MCK trading at a forward earnings multiple of ~18x and estimated 18–22% upside by March 2028.

zacks.com · 2 jul

Here's Why You Should Retain McKesson Stock in Your Portfolio for Now

McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.

zacks.com · 2 jul

Here's Why McKesson (MCK) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com · 30 jun

Here's Why McKesson (MCK) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com · 29 jun

McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know

McKesson (MCK) concluded the recent trading session at $747.53, signifying a -2.09% move from its prior day's close.

zacks.com · 26 jun

Why McKesson (MCK) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com · 24 jun

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

businesswire.com · 24 jun

McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services lea.